Beranda › Skleroderma Difus › Pennsylvania
Uji klinis Skleroderma Difus di Pennsylvania
6 studi untuk Skleroderma Difus mencari peserta di lokasi di Pennsylvania.
Kota di Pennsylvania
Teks studi resmi (Bahasa Inggris)
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- EncompaSSc site in Philadelphia, PA, Philadelphia
- EncompaSSc site in Pittsburgh, PA, Pittsburgh
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07287670A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Pittsburgh
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05878717Platform Clinical Study for Conquering Scleroderma
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06195072Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
Menerima pesertaFase 2
Usia 8 hingga 60 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT03630211The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
- University of Pittsburgh and UPMC Scleroderma Center, Pittsburgh
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jan 2026 · NCT06675344Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.